Lakeridge Wealth Management’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$608K Buy
2,885
+13
+0.5% +$2.79K 0.22% 91
2026
Q1
$635K Buy
2,872
+10
+0.3% +$2.45K 0.27% 79
2025
Q4
$725K Buy
2,862
+13
+0.5% +$3.27K 0.33% 61
2025
Q3
$705K Buy
2,849
+73
+3% +$17.5K 0.31% 61
2025
Q2
$667K Buy
2,776
+6
+0.2% +$1.4K 0.31% 61
2025
Q1
$628K Sell
2,770
-31
-1% -$6.82K 0.31% 57
2024
Q4
$576K Buy
2,801
+95
+4% +$20.8K 0.3% 71
2024
Q3
$656K Buy
2,706
+7
+0.3% +$1.64K 0.36% 54
2024
Q2
$593K Buy
2,699
+5
+0.2% +$1.09K 0.36% 56
2024
Q1
$606K Buy
2,694
+7
+0.3% +$1.58K 0.39% 50
2023
Q4
$591K Buy
+2,687
New +$568K 0.43% 47

Other funds holding STE

Lakeridge Wealth Management's STE Position: Q2 2026 in Review

Lakeridge Wealth Management increased its Steris (STE) stake by 0.45% in Q2 2026, buying an estimated $2.79K and bringing the position to 2,885 shares worth $608K. The position accounts for 0.22% of the portfolio, ranked #91.

Lakeridge Wealth Management first reported a position in STE in Q4 2023 and has held it in 11 quarters since. The position peaked at $725K in Q4 2025. 835 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Lakeridge Wealth Management held 2,885 shares of Steris worth $608K as of Q2 2026.
  • Lakeridge Wealth Management bought 13 Steris shares in Q2 2026, an estimated $2.79K.
  • Steris made up 0.22% of Lakeridge Wealth Management's portfolio in Q2 2026, its #91 holding.
  • Lakeridge Wealth Management first reported a position in Steris in Q4 2023 and has held it in 11 quarters since.
  • Lakeridge Wealth Management's Steris position peaked at $725K in Q4 2025.
  • 835 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Lakeridge Wealth Management's 13F filing for Q2 2026, filed 14 Jul 2026.